跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
QUETIAPINA PENSA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Approved
STANDARD
QUETIAPINA PENSA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Towa Pharmaceutical S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 12, 2021
Approval ID
6745b1de9ac6e37b
Company
Towa Pharmaceutical S.A.
Type
Standard
Approval Details
Approval Id
6745b1de9ac6e37b
Drug Cima Aemps Name
QUETIAPINA PENSA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Register Number
85768
Holder Company Name
Towa Pharmaceutical S.A.
Marketing Company Name
Towa Pharmaceutical S.A.
Authorization Date
2021-02-12
Dosage Form
COMPRIMIDO DE LIBERACIÓN PROLONGADA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Towa Pharmaceutical S.A.
Active Ingredients
QUETIAPINA FUMARATO
172,68 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 12, 2021
Approval ID
6745b1de9ac6e37b
Type
Standard
Back to CIMA-AEMPS Approvals
QUETIAPINA PENSA 150 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG - CIMA-AEMPS Drug Approval Details